Literature DB >> 15139000

Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids.

William H Catherino1, Phyllis C Leppert, Matthew H Stenmark, Mark Payson, Clariss Potlog-Nahari, Lynnette K Nieman, James H Segars.   

Abstract

Uterine leiomyomas are prevalent estrogen-responsive clonal tumors, but the specific genetic alterations that contribute to their development have not been elucidated. To identify genes involved in the formation of leiomyomas, we used global expression profiling to compare clonal tumors with normal myometrium. Contrary to expectation, genes involved in estrogen action were not differentially expressed between leiomyoma and normal myometrium. Genes encoding extracellular-matrix proteins were prominently featured, suggesting their involvement in formation of a myofibroblast phenotype. Analysis of the extracellular matrix in the leiomyomas revealed a disordered collagen fibril orientation. Expression of the collagen-binding protein dermatopontin was found to be consistently decreased in leiomyoma by both reverse transcriptase-polymerase chain reaction (RT-PCR) and real-time RT-PCR (mean underexpression = 9.41-fold) regardless of leiomyoma size, leiomyoma location, patient race, and patient age. This expression pattern was observed in 11 subjects and a total of 23 leiomyoma:myometrium pairs. Decreased expression of dermatopontin was also associated with keloid formation, a fibrotic disease that shares epidemiologic similarities with leiomyoma. Immunohistochemical studies of leiomyomas and keloids demonstrated reduced levels of dermatopontin in both tissues. In addition, ultrastructural analysis revealed that the orientation of the collagen fibrils in the keloid tissues strongly resembled that in the leiomyomas. Reduction in dermatopontin was associated with an increase in transforming growth factor-beta3 (TGFB3) mRNA levels in leiomyomas, whereas other genes involved in dermatopontin signaling were not differentially expressed. These findings suggest that leiomyoma development involves a myofibroblast cell phenotype characterized by dysregulation of genes encoding extracellular-matrix proteins. In particular, decreased expression of dermatopontin represents a molecular link between the leiomyoma and keloid phenotypes. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15139000      PMCID: PMC4152899          DOI: 10.1002/gcc.20035

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  47 in total

1.  Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy.

Authors:  Nasser Chegini; Juan Verala; Xiaoping Luo; Jingxia Xu; R Stan Williams
Journal:  J Soc Gynecol Investig       Date:  2003-04

Review 2.  The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth.

Authors:  R V Iozzo
Journal:  Crit Rev Biochem Mol Biol       Date:  1997       Impact factor: 8.250

3.  Fibrillar collagen specifically regulates human vascular smooth muscle cell genes involved in cellular responses and the pericellular matrix environment.

Authors:  T Ichii; H Koyama; S Tanaka; S Kim; A Shioi; Y Okuno; E W Raines; H Iwao; S Otani; Y Nishizawa
Journal:  Circ Res       Date:  2001-03-16       Impact factor: 17.367

4.  Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon.

Authors:  K G Vogel; M Paulsson; D Heinegård
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

5.  Ontogeny of expression of transforming growth factor-beta 1 (TGF-beta 1), TGF-beta 3, and TGF-beta receptors I and II in fetal rat fibroblasts and skin.

Authors:  M Hsu; Z M Peled; G S Chin; W Liu; M T Longaker
Journal:  Plast Reconstr Surg       Date:  2001-06       Impact factor: 4.730

6.  Tyrosine-rich acidic matrix protein (TRAMP) accelerates collagen fibril formation in vitro.

Authors:  J R MacBeath; D R Shackleton; D J Hulmes
Journal:  J Biol Chem       Date:  1993-09-15       Impact factor: 5.157

7.  Expression of transforming growth factor-beta isoforms (beta 2 and beta 3) in the mouse uterus: analysis of the periimplantation period and effects of ovarian steroids.

Authors:  S K Das; K C Flanders; G K Andrews; S K Dey
Journal:  Endocrinology       Date:  1992-06       Impact factor: 4.736

8.  Cutaneous leiomyomata with uterine leiomyomata.

Authors:  W B Reed; R Walker; R Horowitz
Journal:  Acta Derm Venereol       Date:  1973       Impact factor: 4.437

9.  An immunohistochemical study of the extracellular matrix in oral squamous cell carcinoma and its association with invasive and metastatic potential.

Authors:  T Harada; M Shinohara; S Nakamura; M Oka
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 10.  Etiology and pathogenesis of uterine leiomyomas: a review.

Authors:  Gordon P Flake; Janet Andersen; Darlene Dixon
Journal:  Environ Health Perspect       Date:  2003-06       Impact factor: 9.031

View more
  64 in total

1.  1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model.

Authors:  Sunil K Halder; Chakradhari Sharan; Ayman Al-Hendy
Journal:  Biol Reprod       Date:  2012-04-19       Impact factor: 4.285

2.  Diffusion-weighted and diffusion-tensor imaging of normal and diseased uterus.

Authors:  Duygu Kara Bozkurt; Murat Bozkurt; Mehmet Ali Nazli; Ilhan Nahit Mutlu; Ozgur Kilickesmez
Journal:  World J Radiol       Date:  2015-07-28

Review 3.  Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy.

Authors:  Mostafa A Borahay; Ayman Al-Hendy; Gokhan S Kilic; Darren Boehning
Journal:  Mol Med       Date:  2015-04-13       Impact factor: 6.354

Review 4.  A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays.

Authors:  Phyllis C Leppert; William H Catherino; James H Segars
Journal:  Am J Obstet Gynecol       Date:  2006-04-25       Impact factor: 8.661

5.  Gonadotropin-releasing hormone agonist increases expression of osmotic response genes in leiomyoma cells.

Authors:  Desireé M McCarthy-Keith; Minnie Malik; Joy Britten; James Segars; William H Catherino
Journal:  Fertil Steril       Date:  2011-04-15       Impact factor: 7.329

6.  Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways.

Authors:  Joan C Smith; Braden E Boone; Susan R Opalenik; Scott M Williams; Shirley B Russell
Journal:  J Invest Dermatol       Date:  2007-11-08       Impact factor: 8.551

7.  Activating transcription factor 3 gene expression suggests that tissue stress plays a role in leiomyoma development.

Authors:  Mark Payson; Minnie Malik; Sarah Siti-Nur Morris; James H Segars; Rebecca Chason; William H Catherino
Journal:  Fertil Steril       Date:  2008-08-09       Impact factor: 7.329

8.  Differential expression of microRNA species in human uterine leiomyoma versus normal myometrium.

Authors:  Erica E Marsh; Zhihong Lin; Ping Yin; Magdy Milad; Debabrata Chakravarti; Serdar E Bulun
Journal:  Fertil Steril       Date:  2007-09-04       Impact factor: 7.329

9.  Human uterine smooth muscle and leiomyoma cells differ in their rapid 17beta-estradiol signaling: implications for proliferation.

Authors:  Erica N Nierth-Simpson; Melvenia M Martin; Tung-Chin Chiang; Lilia I Melnik; Lyndsay V Rhodes; Shannon E Muir; Matthew E Burow; John A McLachlan
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

Review 10.  Leiomyomata uteri: hormonal and molecular determinants of growth.

Authors:  Richard Enrique Blake
Journal:  J Natl Med Assoc       Date:  2007-10       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.